Results
|
4421.
|
Phase II study of irinotecan as a third- or fourth-line treatment for advanced non-small cell lung cancer: NJLCG0703. [electronic resource] by
- Matsubara, Nobumichi
- Maemondo, Makoto
- Inoue, Akira
- Ishimoto, Osamu
- Watanabe, Kana
- Sakakibara, Tomohiro
- Fukuhara, Tatsuro
- Morikawa, Naoto
- Tanaka, Masashi
- Sugawara, Shunichi
- Nukiwa, Toshihiro
Producer: 20140403
In:
Respiratory investigation vol. 51
Availability: No items available.
|
|
4422.
|
|
|
4423.
|
|
|
4424.
|
|
|
4425.
|
Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression. [electronic resource] by
- Kang, Min H
- Wang, Jing
- Makena, Monish R
- Lee, Joo-Sang
- Paz, Nancy
- Hall, Connor P
- Song, Michael M
- Calderon, Ruben I
- Cruz, Riza E
- Hindle, Ashly
- Ko, Winford
- Fitzgerald, Jonathan B
- Drummond, Daryl C
- Triche, Timothy J
- Reynolds, C Patrick
Producer: 20160318
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21
Availability: No items available.
|
|
4426.
|
|
|
4427.
|
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). [electronic resource] by
- Fangusaro, Jason
- Gururangan, Sridharan
- Poussaint, Tina Young
- McLendon, Roger E
- Onar-Thomas, Arzu
- Warren, Katherine E
- Wu, Shengjie
- Packer, Roger J
- Banerjee, Anu
- Gilbertson, Richard J
- Jakacki, Regina
- Gajjar, Amar
- Goldman, Stewart
- Pollack, Ian F
- Friedman, Henry S
- Boyett, James M
- Kun, Larry E
- Fouladi, Maryam
Producer: 20140116
In:
Cancer vol. 119
Availability: No items available.
|
|
4428.
|
|
|
4429.
|
|
|
4430.
|
|
|
4431.
|
Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. [electronic resource] by
- Stainthorpe, Angela
- Greenhalgh, Janette
- Bagust, Adrian
- Richardson, Marty
- Boland, Angela
- Beale, Sophie
- Duarte, Rui
- Kotas, Eleanor
- Banks, Lindsay
- Palmer, Daniel
Producer: 20190923
In:
PharmacoEconomics vol. 36
Availability: No items available.
|
|
4432.
|
|
|
4433.
|
|
|
4434.
|
|
|
4435.
|
|
|
4436.
|
Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. [electronic resource] by
- da Silva, Wânia Cristina
- de Araujo, Vânia Eloisa
- Lima, Ellias Magalhães E Abreu
- Dos Santos, Jessica Barreto Ribeiro
- Silva, Michael Ruberson Ribeiro da
- Almeida, Paulo Henrique Ribeiro Fernandes
- de Assis Acurcio, Francisco
- Godman, Brian
- Kurdi, Amanj
- Cherchiglia, Mariângela Leal
- Andrade, Eli Iola Gurgel
Producer: 20190503
In:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 32
Availability: No items available.
|
|
4437.
|
A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. [electronic resource] by
- Lui, Arthur
- Mulder, Karen
- Brezden-Masley, Christine
- Vickers, Michael
- Monzon, Jose
- Kennecke, Hagen
- Goel, Rakesh
- Vos, Larissa
- Ghosh, Sunita
- Marginean, Horia
- Fields, Anthony
- Maroun, Jean
- Spratlin, Jennifer
Producer: 20190327
In:
Investigational new drugs vol. 36
Availability: No items available.
|
|
4438.
|
|
|
4439.
|
Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB [electronic resource] by
- Wang, Zhenjie
- Chi, Dongxu
- Wu, Xingchen
- Wang, Yingli
- Lin, Xinxin
- Xu, Zhaochu
- Liu, Hongzhuo
- Sun, Jin
- He, Zhonggui
- Wang, Yongjun
Producer: 20201026
In:
Journal of controlled release : official journal of the Controlled Release Society vol. 316
Availability: No items available.
|
|
4440.
|
|